These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25758209)

  • 21. Are dyskinesias a problem after neural transplantation for Parkinson's disease?
    Bradbury J
    Lancet; 2002 Jun; 359(9322):2007. PubMed ID: 12076564
    [No Abstract]   [Full Text] [Related]  

  • 22. Dyskinesias following neural transplantation in Parkinson's disease.
    Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
    Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical application of cell grafting techniques in patients with Parkinson's disease.
    Quinn NP
    Prog Brain Res; 1990; 82():619-25. PubMed ID: 2290963
    [No Abstract]   [Full Text] [Related]  

  • 24. Parkinson's transplant therapy faces setback.
    Check E
    Nature; 2003 Aug; 424(6952):987. PubMed ID: 12944933
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantation therapy for Parkinson's disease.
    Borlongan CV
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
    Politis M
    BMC Med; 2010 Dec; 8():80. PubMed ID: 21126348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease.
    Mamelak AN; Eggerding FA; Oh DS; Wilson E; Davis RL; Spitzer R; Hay JA; Caton WL
    J Neurosurg; 1998 Oct; 89(4):592-8. PubMed ID: 9761053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A series of experimental surgery for advanced Parkinson's disease by foetal mesencephalic transplantation.
    Hitchcock ER; Kenny BG; Henderson BT; Clough CG; Hughes RC; Detta A
    Acta Neurochir Suppl (Wien); 1991; 52():54-7. PubMed ID: 1792968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroscience. Fetal cells again?
    Holden C
    Science; 2009 Oct; 326(5951):358-9. PubMed ID: 19833936
    [No Abstract]   [Full Text] [Related]  

  • 30. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL; Brundin P; Cenci MA
    Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease.
    Hildt E
    Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682
    [No Abstract]   [Full Text] [Related]  

  • 33. Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease.
    Widner H; Brundin P; Rehncrona S; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC; Marsden CD; Björklund A
    Transplant Proc; 1991 Feb; 23(1 Pt 1):793-5. PubMed ID: 1990693
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinson disease. Stem cell transplantation.
    Lindvall O
    Lancet; 2001 Dec; 358 Suppl():S48. PubMed ID: 11784596
    [No Abstract]   [Full Text] [Related]  

  • 36. Buspirone in the management of disruptive behaviors due to Huntington's disease and other neurological disorders.
    Bhandary AN; Masand PS
    Psychosomatics; 1997; 38(4):389-91. PubMed ID: 9217410
    [No Abstract]   [Full Text] [Related]  

  • 37. Benefits and risks of hosting animal cells in the human brain.
    Isacson O; Breakefield XO
    Nat Med; 1997 Sep; 3(9):964-9. PubMed ID: 9288721
    [No Abstract]   [Full Text] [Related]  

  • 38. Fetal cell implantation to treat Parkinson's disease: questions for the future.
    Kondziolka D
    Neurosurgery; 2001 Sep; 49(3):582-5. PubMed ID: 11523667
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients.
    Redmond DE; Robbins RJ; Naftolin F; Marek KL; Vollmer TL; Leranth C; Roth RH; Price LH; Gjedde A; Bunney BS
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():325-59. PubMed ID: 8417471
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transplantation of dopamine producing nerve cells: a new therapy in idiopathic Parkinson syndrome?].
    Kupsch A; Sauer H; Oertel WH
    Nervenarzt; 1991 Feb; 62(2):80-91. PubMed ID: 1903517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.